By - Amazon: Jefferies still considers the stock as a Buy opportunity. Previously set at USD 135, the target price has been raised to USD 150.
- Barclays: BNP Paribas Exane remains Outperform with a price target reduced from 235 to 205 GBp.
- Entain: BNP Paribas Exane upgrades to outperform from neutral. PT up 21% to 1,500 pence.
- Fedex: Goldman Sachs maintains his Buy rating on the stock. The target price has been raised from USD 258 to USD 269.
- Hikma: Liberum starts tracking with a Buy rating, targeting 2350 GBp.
- Lloyds Banking Group: BNP Paribas Exane downgrades from outperform to neutral, targeting GBp 52.
- Lookers: Liberum downgrades to hold from buy. PT up 1% to 120 pence.
- NatWest: BNP Paribas Exane downgrades from neutral to underperform, targeting GBp 280.
- Nike: Goldman Sachs advises its customers to buy the stock. Previously set at USD 148, the target price has been slightly modified to USD 144.
- Oxford Biomedica: J.P. Morgan starts tracking at neutral, targeting GBp 495.
- St. James's Place: Barclays moves from Equal-Weight to Overweight, targeting GBp 1,500.
- Tesla: Barclays downgrades to equal-weight from overweight. PT down 5.3% to $260.
- Tyler Tech: J.P. Morgan initiated coverage with a recommendation of overweight. PT set to $472.
ANALYST RECOMMENDATIONS : Amazon, Fedex, NatWest, Nike, Tesla...
June 21, 2023 at 06:07 am EDT
Share
Every morning, find a selection of analysts' recommendations covering North America and the UK. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.
Share
Chief Editor
